Profile
Celiac is a nonprofit organization headquartered in the USA, primarily focused on raising awareness and supporting research related to celiac disease. Established to serve the needs of people with the condition, the organization offers educational resources, advocacy, and a patient registry to aid in scientific studies. It is composed of a diverse team of leaders, advisors, and staff dedicated to providing accurate information and support to those affected by celiac disease and their families.
The organization’s activities include advancing research through patient registries and trials, as well as providing gluten-free resources and policy advocacy. Their educational efforts encompass virtual events and the dissemination of research findings associated with celiac disease. Though not an investment firm, Celiac channels its contributions and resources towards impactful programs and initiatives aimed at improving the lives of individuals with celiac disease.
With supportive efforts from donors and financial backing, Celiac helps foster a collaborative network of patients, medical professionals, and researchers. Their strategic partnerships and sponsorships enable them to drive initiatives and promote a deeper understanding of celiac disease through various campaigns and educational outreach programs.
Industry
Celiac Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Celiac Disease Foundation Impact Fund
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$15 M
|
March 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.